Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm
Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant...
Gespeichert in:
Veröffentlicht in: | International journal of antimicrobial agents 2011-04, Vol.37 (4), p.324-331 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 331 |
---|---|
container_issue | 4 |
container_start_page | 324 |
container_title | International journal of antimicrobial agents |
container_volume | 37 |
creator | Rivardo, Fabrizio Martinotti, Maria Giovanna Turner, Raymond Joseph Ceri, Howard |
description | Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm. |
doi_str_mv | 10.1016/j.ijantimicag.2010.12.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_858285873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0924857911000197</els_id><sourcerecordid>858285873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCX4BwQD1l8dhxYl-QqlULSJU4bHu2HGeyO0u-sBPQ_nscdvkQJ062rOedef3OJMkbYGtgULw7rOlg-4k6cna35mx552sG8CRZgSp5VmoQT5MV0zzPlCz1RXIZwoExkCKXz5MLDgIK0OUq2W-PPfodhYlcik2DbkqHJm1pHEYcJ6oxrWgIs2-sm2LP9DtN-3RpHp-jJqR2Z6kPU3ob3B49uT3Z1A0tpZu7B1aKRd5Q271InjW2DfjyfF4lj3e3D5uP2f3nD582N_eZy5WcsjL6crqpFVcKKlsxbZUtZCnyiiMHWyGUkqMt4h2twKLSosyhzquaQyWEuEquT3VHP3ydMUymo-CwbW2PwxyMkrG0VOVC6hPp_BCCx8aMnjrrjwaYWXI2B_NXzmbJ2QA3MeeofXXuMlcd1r-Vv4KNwNszYIOzbeNt7yj84YRWgkkdudcnrrGDsTsfmcdt7CTjsBQXP21uTgTG1L4RehMcYe-wJh-nZeqB_svw-3-quJb6iLVf8IjhMMy-j2MxYEIUmO2yOsvmALDoJH7oB17qwGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858285873</pqid></control><display><type>article</type><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</creator><creatorcontrib>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</creatorcontrib><description>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</description><identifier>ISSN: 0924-8579</identifier><identifier>EISSN: 1872-7913</identifier><identifier>DOI: 10.1016/j.ijantimicag.2010.12.011</identifier><identifier>PMID: 21316197</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-Bacterial Agents - pharmacology ; anti-infective properties ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacillus licheniformis ; Biofilm ; Biofilms ; Biological and medical sciences ; Biosurfactant ; biosurfactants ; catheters ; cefazolin ; ceftriaxone ; ciprofloxacin ; Eradication ; Escherichia coli ; Escherichia coli - drug effects ; Infectious Disease ; Lipopeptide ; lipopeptides ; Lipopeptides - pharmacology ; Medical sciences ; Microbial Sensitivity Tests ; microorganisms ; Microscopy, Confocal ; pathogens ; Pharmacology. Drug treatments ; piperacillin ; polystyrenes ; sulfamethoxazole ; Surface-Active Agents - pharmacology ; synergism ; Synergy ; tobramycin ; trimethoprim ; Uropathogenic Escherichia coli</subject><ispartof>International journal of antimicrobial agents, 2011-04, Vol.37 (4), p.324-331</ispartof><rights>Elsevier B.V. and the International Society of Chemotherapy</rights><rights>2011 Elsevier B.V. and the International Society of Chemotherapy</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</citedby><cites>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0924857911000197$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23983059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21316197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivardo, Fabrizio</creatorcontrib><creatorcontrib>Martinotti, Maria Giovanna</creatorcontrib><creatorcontrib>Turner, Raymond Joseph</creatorcontrib><creatorcontrib>Ceri, Howard</creatorcontrib><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><title>International journal of antimicrobial agents</title><addtitle>Int J Antimicrob Agents</addtitle><description>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>anti-infective properties</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacillus licheniformis</subject><subject>Biofilm</subject><subject>Biofilms</subject><subject>Biological and medical sciences</subject><subject>Biosurfactant</subject><subject>biosurfactants</subject><subject>catheters</subject><subject>cefazolin</subject><subject>ceftriaxone</subject><subject>ciprofloxacin</subject><subject>Eradication</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Infectious Disease</subject><subject>Lipopeptide</subject><subject>lipopeptides</subject><subject>Lipopeptides - pharmacology</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>microorganisms</subject><subject>Microscopy, Confocal</subject><subject>pathogens</subject><subject>Pharmacology. Drug treatments</subject><subject>piperacillin</subject><subject>polystyrenes</subject><subject>sulfamethoxazole</subject><subject>Surface-Active Agents - pharmacology</subject><subject>synergism</subject><subject>Synergy</subject><subject>tobramycin</subject><subject>trimethoprim</subject><subject>Uropathogenic Escherichia coli</subject><issn>0924-8579</issn><issn>1872-7913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEotvCX4BwQD1l8dhxYl-QqlULSJU4bHu2HGeyO0u-sBPQ_nscdvkQJ062rOedef3OJMkbYGtgULw7rOlg-4k6cna35mx552sG8CRZgSp5VmoQT5MV0zzPlCz1RXIZwoExkCKXz5MLDgIK0OUq2W-PPfodhYlcik2DbkqHJm1pHEYcJ6oxrWgIs2-sm2LP9DtN-3RpHp-jJqR2Z6kPU3ob3B49uT3Z1A0tpZu7B1aKRd5Q271InjW2DfjyfF4lj3e3D5uP2f3nD582N_eZy5WcsjL6crqpFVcKKlsxbZUtZCnyiiMHWyGUkqMt4h2twKLSosyhzquaQyWEuEquT3VHP3ydMUymo-CwbW2PwxyMkrG0VOVC6hPp_BCCx8aMnjrrjwaYWXI2B_NXzmbJ2QA3MeeofXXuMlcd1r-Vv4KNwNszYIOzbeNt7yj84YRWgkkdudcnrrGDsTsfmcdt7CTjsBQXP21uTgTG1L4RehMcYe-wJh-nZeqB_svw-3-quJb6iLVf8IjhMMy-j2MxYEIUmO2yOsvmALDoJH7oB17qwGQ</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Rivardo, Fabrizio</creator><creator>Martinotti, Maria Giovanna</creator><creator>Turner, Raymond Joseph</creator><creator>Ceri, Howard</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110401</creationdate><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><author>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>anti-infective properties</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacillus licheniformis</topic><topic>Biofilm</topic><topic>Biofilms</topic><topic>Biological and medical sciences</topic><topic>Biosurfactant</topic><topic>biosurfactants</topic><topic>catheters</topic><topic>cefazolin</topic><topic>ceftriaxone</topic><topic>ciprofloxacin</topic><topic>Eradication</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Infectious Disease</topic><topic>Lipopeptide</topic><topic>lipopeptides</topic><topic>Lipopeptides - pharmacology</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>microorganisms</topic><topic>Microscopy, Confocal</topic><topic>pathogens</topic><topic>Pharmacology. Drug treatments</topic><topic>piperacillin</topic><topic>polystyrenes</topic><topic>sulfamethoxazole</topic><topic>Surface-Active Agents - pharmacology</topic><topic>synergism</topic><topic>Synergy</topic><topic>tobramycin</topic><topic>trimethoprim</topic><topic>Uropathogenic Escherichia coli</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivardo, Fabrizio</creatorcontrib><creatorcontrib>Martinotti, Maria Giovanna</creatorcontrib><creatorcontrib>Turner, Raymond Joseph</creatorcontrib><creatorcontrib>Ceri, Howard</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of antimicrobial agents</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivardo, Fabrizio</au><au>Martinotti, Maria Giovanna</au><au>Turner, Raymond Joseph</au><au>Ceri, Howard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</atitle><jtitle>International journal of antimicrobial agents</jtitle><addtitle>Int J Antimicrob Agents</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>37</volume><issue>4</issue><spage>324</spage><epage>331</epage><pages>324-331</pages><issn>0924-8579</issn><eissn>1872-7913</eissn><abstract>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>21316197</pmid><doi>10.1016/j.ijantimicag.2010.12.011</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0924-8579 |
ispartof | International journal of antimicrobial agents, 2011-04, Vol.37 (4), p.324-331 |
issn | 0924-8579 1872-7913 |
language | eng |
recordid | cdi_proquest_miscellaneous_858285873 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Anti-Bacterial Agents - pharmacology anti-infective properties Antibiotics. Antiinfectious agents. Antiparasitic agents Bacillus licheniformis Biofilm Biofilms Biological and medical sciences Biosurfactant biosurfactants catheters cefazolin ceftriaxone ciprofloxacin Eradication Escherichia coli Escherichia coli - drug effects Infectious Disease Lipopeptide lipopeptides Lipopeptides - pharmacology Medical sciences Microbial Sensitivity Tests microorganisms Microscopy, Confocal pathogens Pharmacology. Drug treatments piperacillin polystyrenes sulfamethoxazole Surface-Active Agents - pharmacology synergism Synergy tobramycin trimethoprim Uropathogenic Escherichia coli |
title | Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A59%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20effect%20of%20lipopeptide%20biosurfactant%20with%20antibiotics%20against%20Escherichia%20coli%20CFT073%20biofilm&rft.jtitle=International%20journal%20of%20antimicrobial%20agents&rft.au=Rivardo,%20Fabrizio&rft.date=2011-04-01&rft.volume=37&rft.issue=4&rft.spage=324&rft.epage=331&rft.pages=324-331&rft.issn=0924-8579&rft.eissn=1872-7913&rft_id=info:doi/10.1016/j.ijantimicag.2010.12.011&rft_dat=%3Cproquest_cross%3E858285873%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=858285873&rft_id=info:pmid/21316197&rft_els_id=1_s2_0_S0924857911000197&rfr_iscdi=true |